SciCann Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

SciCann Therapeutics General Information

Description

Developer of cannabis and cannabinoid-based therapeutics products designed to target and modulate the endocannabinoid system. The company's products are dedicated to the discovery and development of novel and proprietary technologies in the cannabinoid space, including new therapeutic agents, drug candidates, novel cannabis genetics, and personalized treatment tools, enabling medical professionals the treatment of chosen life-threatening conditions that present a high level of unmet need for performing its R&D programs quickly and efficiently.

Contact Information

Website
www.scicann.net
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 69 Yonge Street
  • Suite 1010
  • Toronto, Ontario M5E 1J1
  • Canada
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • 69 Yonge Street
  • Suite 1010
  • Toronto, Ontario M5E 1J1
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SciCann Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 14-Jul-2022 Completed Out of Business
2. Early Stage VC 28-May-2018 Completed Product Development
1. Early Stage VC 01-May-2018 Completed Startup
To view SciCann Therapeutics’s complete valuation and funding history, request access »

SciCann Therapeutics Patents

SciCann Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3946315-A1 Cannabinoid compositions and use thereof Inactive 28-Mar-2019
EP-3946315-A4 Cannabinoid compositions and use thereof Inactive 28-Mar-2019
US-20220151982-A1 Cannabinoid compositions and use thereof Inactive 28-Mar-2019
WO-2020194237-A1 Cannabinoid compositions and use thereof Inactive 28-Mar-2019
WO-2019159176-A1 Compositions and methods for treatment of neurodegenerative diseases Inactive 18-Feb-2018 A61K36/61
To view SciCann Therapeutics’s complete patent history, request access »

SciCann Therapeutics FAQs

  • When was SciCann Therapeutics founded?

    SciCann Therapeutics was founded in 2017.

  • Where is SciCann Therapeutics headquartered?

    SciCann Therapeutics is headquartered in Toronto, Canada.

  • What industry is SciCann Therapeutics in?

    SciCann Therapeutics’s primary industry is Pharmaceuticals.

  • Is SciCann Therapeutics a private or public company?

    SciCann Therapeutics is a Private company.

  • What is SciCann Therapeutics’s current revenue?

    The current revenue for SciCann Therapeutics is .

  • How much funding has SciCann Therapeutics raised over time?

    SciCann Therapeutics has raised $3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process